NDTV·1 min read·easy
0%, 100%, 200%: Trump's New Generic Drug Tariff Plan May Impact India
✦AI Summary
Donald Trump's proposed tariff plan on generic drugs could significantly impact India, which is a major supplier of generic medicines to the United States. Indian generics currently account for nearly 40 percent of the U.S. market by volume.
India is often called the "pharmacy of the world" as it supplies generic medicines to countries across the globe. In the US, Indian generic medicines make up nearly 40 per cent by volume.
economyhealthpolitics
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in